Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Атмосфера. Новости кардиологии
2018 / N 4

Микрососудистая стенокардия: вопросы диагностики и лечения 2019 г.
Ю.А. Карпов, Г.Н. Соболева, Е.А. Ерпылова

Список литературы

1. Russian Society of Cardiology, Russian National Atherosclerosis Society, Russian National Atherothrombosis Society. Clinical guidelines. Stable coronary heart disease 2016. ICD 10: I20.1 / I20.8 / I20.9 / I25.0 / I25.1 / I25.2 / I25.5 / I25.6 / I25.8 / I25.9. Year of approval: 2016. Available from: http://cr.rosminzdrav.ru/#!/schema/133 Accessed 2018 Dec 12. (In Russian).
2. Task Force Members; Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines; Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. European Heart Journal 2013 Oct;34(38):2949-3003.
3. Federal State Statistics Service (Rosstat). Russia in numbers 2017. Moscow, 2017. 511 p. Available from: http://www.gks.ru/free_doc/doc_2017/zdrav17.pdf Accessed 2018 Dec 12 (In Russian).
4. Humphries KH, Pu A, Gao M, Carere RG, Pilote L. Angina with “normal” coronary arteries: sex differences in outcomes. American Heart Journal 2008 Feb;155(2):375-81.
5. Ouellette M, Löffler AI, Beller GA, Workman VK, Holland E, Bourque JM. Clinical characteristics, sex differences, and outcomes in patients with normal or near normal coronary arteries, non obstructive or obstructive coronary artery disease. Journal of American Heart Association 2018 May;7(10). pii: e007965. doi: 10.1161/JAHA.117.007965.
6. Proudfit WL, Shirey EK, Sones FM Jr. Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients. Circulation 1966 Jun;33(6):901-10.
7. Sandler KM, McNaughton CD, Presley MA, Williams JR. Incidence and management of mild coronary atherosclerotic disease diagnosed with coronary CTA in the emergency department. Emergency Medicine (Los Angeles) 2015;5:6.
8. Kemp HG, Kronmal RA, Vliestra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms. A CASS registry study. Journal of the American College of Cardiology 1986;7:479-83.
9. Cannon RO 3rd, Epstein SE. ‘Microvascular angina’ as a cause of chest pain with angiographically normal coronary arteries. The American Journal of Cardiology 1988 Jun;61(15):1338-43.
10. Lanza GA, De Vita A, Kaski JC. ‘Primary’ microvascular angina: clinical characteristics, pathogenesis and management. Journal of Interventional Cardiology 2018 Sep;13(3):108-11.
11. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. European Heart Journal 2014 May;35(17):1101-11.
12. Sergiyenko VB, Sayutina EV, Samoylenko LE, Samko AN, Pershukov IV, Levitskiy IV, Soboleva GN, Karpov YuA. Role of endothelial dysfunction in development of myocardial ischemia in patients with coronary heart disease and unchanged or minimally changed coronary arteries. Kardiologiia 1999;39(1):25-30 (In Russian).
13. Lanza GA, Crea F. Primary coronary microvascular dysfunction clinical presentation, pathophysiology, and management. Circulation 2010 Jun;121(21):2317-25.
14. Villano A, Lanza GA, Crea F. Microvascular angina: prevalence, pathophysiology and therapy. Journal of Cardiovascular Medicine (Hagerstown, Md) 2018 Feb;19(Suppl 1):e36-9.
15. Camici PG, Crea F. Coronary microvascular dysfunction. The New England Journal of Medicine 2007 Feb;356(8):830-40.
16. Patel MB, Bui LP, Kirkeeide RL, Gould KL. Imaging microvascular dysfunction and mechanisms for female–male differences in CAD. JACC. Cardiovascular Imaging 2016 Apr;9(4):465-82.
17. Cannon RO, Watson RM, Rosing DR, Epstein SE. Angina caused by reduced vasodilator reserve of the small coronary arteries. Journal of the American College of Cardiology 1983 Jun;1(6):1359-73.
18. Kaski JC, Valenzuela Garcia LF. Therapeutic options for the management of patients with cardiac syndrome X. European Heart Journal 2001 Feb;22(4):283-93.
19. Lanza GA, Buffon A, Sestito A, Natale L, Sgueglia GA, Galiuto L, Infusino F, Mariani L, Centola A, Crea F. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. Journal of the American College of Cardiology 2008 Jan;51(4):466-72.
20. Rodés-Cabau J, Gutiérrez M, Courtis J, Larose E, Déry JP, Côté M, Nguyen CM, Gleeton O, Proulx G, Roy L, Noël B, Barbeau G, De Larochellière R, Rinfret S, Bertrand OF. Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements. The American Journal of Cardiology 2011 Aug;108(4):483-90.
21. Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, Ruddy TD, Sarveswaran N, Tee RE, Beanlands RS. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. Journal of the American College of Cardiology 2011 Aug;58(7):740-8.
22. Schelbert HR. Positron emission tomography measurements of myocardial blood flow: assessing coronary circulatory function and clinical implications. Heart 2012 Apr;98(7):592-600.
23. Marinescu MA, Löffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC. Cardiovascular Imaging 2015 Feb;8(2):210-20.
24. Soboleva GN, Gaman SA, Ternovoy SK, Sharia MA, Karpov IE, Karpov YuA. Disturbance of myocardial perfusion in non-obstructive coronary arteries by volumetric computed tomography combined with adenosine triphosphate pharmacological test. Russian Electronic Journal of Radiology 2018;8(3):273-8 (In Russian).
25. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DS. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Annals of Internal Medicine 1999 Apr;130(7):578-81.
26. Gokce N, Vita JA, McDonnell M, Forse AR, Istfan N, Stoeckl M, Lipinska I, Keaney JF Jr, Apovian CM. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. The American Journal of Cardiology 2005 Jan;95(2):266-8.
27. Klonizakis M, Alkhatib A, Middleton G, Smith MF. Mediterranean diet- and exercise-induced improvement in age-dependent vascular activity. Clinical Science (London, England 1979) 2013 May;124(9):579-87.
28. Eriksson BE, Tyni-Lennè R, Svedenhag J, Hallin R, Jensen-Urstad K, Jensen-Urstad M, Bergman K, Selvén C. Physical training in syndrome X: physical training counteracts deconditioning and pain in syndrome X. Journal of the American College of Cardiology 2000 Nov;36(5):1619-25.
29. Lim TK, Choy AJ, Khan F, Belch JJ, Struthers AD, Lang CC. Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiology. Cardiovascular Therapeutic 2009 Spring;27(1):49-8.
30. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotensin-converting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. Journal of the American College of Cardiology 1994 Mar;23(3):652-7.
31. Chen JW, Hsu NW, Wu TC, Lin SJ, Chang MS. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. The American Journal of Cardiology 2002 Nov 1;90(9):974-82.
32. Kayikcioglu M, Paysin A, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome X. European Heart Journal 2003 Nov;24(22):1999-2005.
33. Fábián E, Varga A, Picano E, Vajo Z, Rónaszéki A, Csanády M. Effect of simvastatin on endothelial function in cardiac syndrome X patients. The American Journal of Cardiology 2004 Sep;94(5):652-55.
34. Baller D, Notohamiprodjo G, Gleichmann U, Holzinger J, Weise R, Lehmann J. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation 1999 Jun 8;99(22):2871-5.
35. Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: Role of superoxide dismutase activity. Circulation 2004 Jan;109(1):53-8.
36. Mather KJ, Verma S, Anderson TJ. Improved endothelial function with metformin in type 2 diabetes mellitus. Journal of the American College of Cardiology 2001 Apr;37(5):1344-50.
37. Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. Journal of the American College of Cardiology 2006 Sep;48(3):956-63.
38. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. European Heart Journal 2006 Jun;27(11):1341-81.
39. Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. The American Journal of Cardiology 1999 Oct;84(7):854-6, A8.
40. Bugiardini R, Borghi A, Biagetti L, Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. The American Journal of Cardiology 1989 Feb;63(5):286-90.
41. Togni M, Vigorito F, Windecker S, Abrecht L, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM. Does the beta-blocker nebivolol increase coronary flow reserve? Cardiovascular Drugs and Therapy 2007 Apr;21(2):99-108.
42. Suzuki H, Matsubara H, Koba S, Murakami M, Takeyama Y, Katagiri T. Clinical characteristics and follow-up in patients with microvascular angina. Circulation Journal 2002 Jul;66(7):691-5.
43. Masumoto A, Mohri M, Takeshita A. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. International Journal of Cardiology 2001 Dec;81(2-3):151-6.
44. Kinoshita M, Sakai K. Pharmacology and therapeutic effects of nicorandil. Cardiovascular Drugs and Therapy 1990 Aug;4(4):1075-88.
45. Karpov YuA. Chronic coronary heart disease: treatment news. Consilium Medicum 2016;18(1):38-44 (In Russian).
46. Horinaka S, Yabe A, Yagi H, Ishimitsu T, Yamazaki T, Suzuki S, Kohro T, Nagai R; JCAD Study Investigators. Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circulation Journal 2010 Mar;74(3):503-9.
47. Sakata Y, Nakatani D, Shimizu M, Suna S, Usami M, Matsumoto S, Hara M, Sumitsuji S, Kawano S, Iwakura K, Hamasaki T, Sato H, Nanto S, Hori M, Komuro I. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. Journal of Cardiology 2012 Jan;59(1):14-21.
48. Martsevich SYu, Kutishenko NP, Deyev AD, on behalf of KVAZAR study participants. Comparative evaluation of antianginal efficacy and safety of nicorandil against the background of basic therapy with β-blockers in patients with coronary artery disease and stable angina. Kardiologiia 2016;56(10):30-4 (In Russian).
49. Voronina VP, Martsevich SYu, Kutishenko NP, Deyev AD on behalf of KVAZAR study participants. Evaluation of antianginal and anti-ischemic efficacy of nicorandil by treadmill stress test in KVAZAR study. Russian Journal of Cardiology 2017;22(3):97-103 (In Russian).
50. Martsevich SYu, Kutishenko NP, Deyev AD, on behalf of KVAZAR study participants. Effect of nicorandil on life quality of patients with stable angina according to KVAZAR study. Rational Pharmacotherapy in Cardiology 2016;12(6):654-60 (In Russian).
51. Yamabe H, Namura H, Yano T, Fujita H, Kim S, Iwahashi M, Maeda K, Yokoyama M. Effect of nicorandil on abnormal coronary flow reserve assessed by exercise 201Tl scintigraphy in patients with angina pectoris and nearly normal coronary arteriograms. Cardiovascular Drugs and Therapy 1995 Dec;9(6):755-61.
52. Chen JW, Lee WL, Hsu NW, Lin SJ, Ting CT, Wang SP, Chang MS. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. The American Journal of Cardiology 1997;80:32-8.
53. Gostishchev RV, Soboleva GN, Samko AN, Minasyan AA. Protective effect of nicorandil on periprocedural myocardial injury in patients with stable coronary heart disease in planned percutaneous coronary interventions. Consilium Medicum 2018;20(5):61-5 (In Russian).
54. Villano A, Di Franco A, Nerla R, Sestito A, Tarzia P, Lamendola P, Di Monaco A, Sarullo FM, Lanza GA, Crea F. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. The American Journal of Cardiology 2013 Jul;112(1):8-13.
55. Allibardi S, Chierchia SL, Margonato V, Merati G, Neri G, Dell’Antonio G, Samaja M. Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts. Cardiovascular Drugs and Therapy 1998 Dec;12(6):543-9.
56. Rogacka D, Guzik P, Wykretowicz A, Rzeźniczak J, Dziarmaga M, Wysocki H. Effects of trimetazidine on clinical symptoms and tolerance of exercise of patients with syndrome X: a preliminary study. Coronary Artery Disease 2000 Mar;11(2):171-7.
57. Nalbantgil S, Altintiğ A, Yilmaz H, Nalbantgil I I, Önder R. The effect of trimetazidine in the treatment of microvascular angina. The International Journal of Angiology 1999 Jan;8(1):40-3.
58. Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC. Cardiovascular Imaging 2011 May;4(5):514-22.
59. Elliott PM, Krzyzowska-Dickinson K, Calvino R, Hann C, Kaski JC. Effect of oral aminophylline in patients with angina and normal coronary arteriograms (cardiac syndrome X). Heart 1997 Jun;77(6):523-6.
60. Cox ID, Hann CM, Kaski JC. Low dose imipramine improves chest pain but not quality of life in patients with angina and normal coronary angiograms. European Heart Journal 1998 Feb;19(2):250-4.
61. Latif OA, Nedeljkovic SS, Stevenson LW. Spinal cord stimulation for chronic intractable angina pectoris: a unified theory on its mechanism. Clinical Cardiology 2001 Aug;24(8):533-41.
62. Sestito A, Lanza GA, Le Pera D, De Armas L, Sgueglia GA, Infusino F, Miliucci R, Tonali PA, Crea F, Valeriani M. Spinal cord stimulation normalizes abnormal cortical pain processing in patients with cardiac syndrome X. Pain 2008 Sep;139(1):82-9.
63. Kaski JC, Elliott PM. Angina pectoris and normal coronary arteriograms: clinical presentation and hemodynamic characteristics. The American Journal of Cardiology 1995 Nov;76(13):35D-42D.
64. Schroeder JS. Emerging therapies for angina: new modalities may offer additional clinical options. Managed Care Interface 2004 Apr;17(4):45-52.
65. Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM; National Institutes of Health-National Heart, Lung, and Blood Institute. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004 Jun;109(24):2993-9.
66. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, Jørgensen E, Kelbæk H, Prescott E. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. European Heart Journal 2012 Mar;33(6):734-44.
67. Tavella R, Cutri N, Tucker G, Adams R, Spertus J, Beltrame JF. Natural history of patients with insignificant coronary artery disease. European Heart Journal. Quality of Care & Clinical Outcomes 2016 Apr 1;2(2):117-24.
68. Lichtlen PR, Bargheer K, Wenzlaff P. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings. Journal of the American College of Cardiology 1995 Apr;25(5):1013-8.
69. Soboleva GN, Fedulov VK, Samko AN, Levitskiy IV, Rogoza AN, Balakhonova TV, Karpov YuA. Prognostic value of endothelial dysfunction in coronary and brachial arteries, and common risk factors in development of cardiovascular complications in patients with microvascular angina. Russian Journal of Cardiology 2017;22(3):54-8 (In Russian).
70. Women’s ischemiA tRial to Reduce events In non-ObstRuctive CAD (WARRIOR). Available from: https://clinicaltrials.gov/ct2/show/NCT03417388 Accessed 2018 Dec 12.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]